41 related articles for article (PubMed ID: 32107374)
1. Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02.
Hasegawa D; Imamura T; Yumura-Yagi K; Takahashi Y; Usami I; Suenobu SI; Nishimura S; Suzuki N; Hashii Y; Deguchi T; Moriya-Saito A; Kato K; Kosaka Y; Hirayama M; Iguchi A; Kawasaki H; Hori H; Sato A; Kudoh T; Nakahata T; Oda M; Hara J; Horibe K;
Blood Cancer J; 2020 Feb; 10(2):23. PubMed ID: 32107374
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.
Gaynon PS; Angiolillo AL; Carroll WL; Nachman JB; Trigg ME; Sather HN; Hunger SP; Devidas M;
Leukemia; 2010 Feb; 24(2):285-97. PubMed ID: 20016531
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group.
Salzer WL; Devidas M; Carroll WL; Winick N; Pullen J; Hunger SP; Camitta BA
Leukemia; 2010 Feb; 24(2):355-70. PubMed ID: 20016527
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.
Pui CH; Pei D; Sandlund JT; Ribeiro RC; Rubnitz JE; Raimondi SC; Onciu M; Campana D; Kun LE; Jeha S; Cheng C; Howard SC; Metzger ML; Bhojwani D; Downing JR; Evans WE; Relling MV
Leukemia; 2010 Feb; 24(2):371-82. PubMed ID: 20010620
[TBL] [Abstract][Full Text] [Related]
5. Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial.
Masurekar AN; Parker CA; Shanyinde M; Moorman AV; Hancock JP; Sutton R; Ancliff PJ; Morgan M; Goulden NJ; Fraser C; Hoogerbrugge PM; Revesz T; Darbyshire PJ; Krishnan S; Love SB; Saha V
PLoS One; 2014; 9(10):e108107. PubMed ID: 25279465
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment Strategies.
Matloub Y; Stork L; Asselin B; Hunger SP; Borowitz M; Jones T; Bostrom B; Gastier-Foster JM; Heerema NA; Carroll A; Winick N; Carroll WL; Camitta B; Devidas M; Gaynon PS
Pediatr Blood Cancer; 2016 Feb; 63(2):255-61. PubMed ID: 26485054
[TBL] [Abstract][Full Text] [Related]
7. Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: a systematic review and meta-analysis.
Kelly MJ; Trikalinos TA; Dahabreh IJ; Gianferante M; Parsons SK
Am J Hematol; 2014 Oct; 89(10):992-7. PubMed ID: 24912665
[TBL] [Abstract][Full Text] [Related]
8. Prednisolone poor response is not an indication for HSCT in pediatric B-cell precursor acute lymphoblastic leukemia in first remission: results from JACLS ALL-02 study.
Ishida H; Yano M; Hasegawa D; Hori T; Hashii Y; Kato K; Deguchi T; Saito A; Sato A; Hori H; Horibe K; Imamura T
Int J Hematol; 2021 Jun; 113(6):893-902. PubMed ID: 33641058
[TBL] [Abstract][Full Text] [Related]
9. Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
Aoki T; Takahashi H; Tanaka S; Shiba N; Hasegawa D; Iwamoto S; Terui K; Moritake H; Nakayama H; Shimada A; Koh K; Goto H; Kosaka Y; Saito AM; Horibe K; Kinoshita A; Tawa A; Taga T; Adachi S; Tomizawa D
Br J Haematol; 2021 Apr; 193(1):176-180. PubMed ID: 32337716
[TBL] [Abstract][Full Text] [Related]
10. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.
Ueno H; Yoshida K; Shiozawa Y; Nannya Y; Iijima-Yamashita Y; Kiyokawa N; Shiraishi Y; Chiba K; Tanaka H; Isobe T; Seki M; Kimura S; Makishima H; Nakagawa MM; Kakiuchi N; Kataoka K; Yoshizato T; Nishijima D; Deguchi T; Ohki K; Sato A; Takahashi H; Hashii Y; Tokimasa S; Hara J; Kosaka Y; Kato K; Inukai T; Takita J; Imamura T; Miyano S; Manabe A; Horibe K; Ogawa S; Sanada M
Blood Adv; 2020 Oct; 4(20):5165-5173. PubMed ID: 33095873
[TBL] [Abstract][Full Text] [Related]
11. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
[TBL] [Abstract][Full Text] [Related]
12. Retrospective computed tomography assessment of chemotherapy-related pneumonia with severity screening in pediatric acute lymphoblastic leukemia by radiological imaging.
Gao Z; Wei K; Chen R; Ye W; Li T; Su Q; Wang R; Cao W
Heliyon; 2024 Jan; 10(1):e23444. PubMed ID: 38169788
[TBL] [Abstract][Full Text] [Related]
13. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.
Kubota H; Ueno H; Tasaka K; Isobe T; Saida S; Kato I; Umeda K; Hiwatari M; Hasegawa D; Imamura T; Kakiuchi N; Nannya Y; Ogawa S; Hiramatsu H; Takita J
Blood Adv; 2024 Mar; 8(5):1258-1271. PubMed ID: 38127276
[TBL] [Abstract][Full Text] [Related]
14. Predicting Long-Term Ventricular Arrhythmia Risk in Children with Acute Lymphoblastic Leukemia Using Normal Values of Ventricular Repolarization Markers Established from Japanese Cohort Study.
Takeguchi M; Kusumoto S; Sekiguchi K; Suenobu S; Ihara K
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510838
[TBL] [Abstract][Full Text] [Related]
15. Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials.
Raetz EA; Rebora P; Conter V; Schrappe M; Devidas M; Escherich G; Imai C; De Moerloose B; Schmiegelow K; Burns MA; Elitzur S; Pieters R; Attarbaschi A; Yeoh A; Pui CH; Stary J; Cario G; Bodmer N; Moorman AV; Buldini B; Vora A; Valsecchi MG
J Clin Oncol; 2023 Nov; 41(32):5025-5034. PubMed ID: 37487146
[TBL] [Abstract][Full Text] [Related]
16. Outcome of hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia not in remission enrolled in JACLS ALL-02.
Yano M; Ishida H; Hara J; Kawaguchi H; Ito E; Moriya-Saito A; Hashii Y; Deguchi T; Miyamura T; Sato A; Hori H; Horibe K; Imamura T
Int J Hematol; 2023 Sep; 118(3):364-373. PubMed ID: 37358749
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia.
Imai C; Sato A; Hiwatari M; Shimomura Y; Hori T; Suenobu S; Imamura T; Hara J; Hasegawa D; Takahashi H; Moriya K; Katayama S; Tomizawa D; Moritake H; Taga T; Horibe K; Koh K; Manabe A; Okamoto Y
Int J Hematol; 2023 Jul; 118(1):99-106. PubMed ID: 37037958
[TBL] [Abstract][Full Text] [Related]
18. Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children.
Haas OA; Borkhardt A
Leukemia; 2022 Dec; 36(12):2769-2783. PubMed ID: 36266323
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/
Attarbaschi A; Möricke A; Harrison CJ; Mann G; Baruchel A; De Moerloose B; Conter V; Devidas M; Elitzur S; Escherich G; Hunger SP; Horibe K; Manabe A; Loh ML; Pieters R; Schmiegelow K; Silverman LB; Stary J; Vora A; Pui CH; Schrappe M; Zimmermann M;
J Clin Oncol; 2023 Mar; 41(7):1404-1422. PubMed ID: 36256911
[TBL] [Abstract][Full Text] [Related]
20. Curing the Curable: Managing Low-Risk Acute Lymphoblastic Leukemia in Resource Limited Countries.
Oh BLZ; Lee SHR; Yeoh AEJ
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
